Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$209.01 - $232.56 $10,450 - $11,628
-50 Reduced 2.51%
1,940 $424,000
Q4 2023

Feb 01, 2024

SELL
$197.69 - $227.29 $512,017 - $588,681
-2,590 Reduced 56.55%
1,990 $452,000
Q3 2023

Oct 31, 2023

SELL
$201.05 - $221.7 $1.02 Million - $1.13 Million
-5,098 Reduced 52.68%
4,580 $921,000
Q2 2023

Jul 20, 2023

SELL
$211.93 - $241.33 $1.23 Million - $1.4 Million
-5,787 Reduced 37.42%
9,678 $2.34 Million
Q1 2023

Apr 20, 2023

SELL
$213.32 - $257.83 $5.76 Million - $6.96 Million
-27,005 Reduced 63.59%
15,465 $3.55 Million
Q3 2022

Oct 25, 2022

BUY
$204.81 - $262.19 $281,613 - $360,511
1,375 Added 3.35%
42,470 $8.7 Million
Q2 2022

Jul 15, 2022

SELL
$213.86 - $277.87 $367,411 - $477,380
-1,718 Reduced 4.01%
41,095 $9.63 Million
Q1 2022

Apr 13, 2022

SELL
$259.82 - $298.18 $193,565 - $222,144
-745 Reduced 1.71%
42,813 $11.3 Million
Q4 2021

Jan 21, 2022

BUY
$271.6 - $314.21 $365,845 - $423,240
1,347 Added 3.19%
43,558 $13.7 Million
Q3 2021

Oct 29, 2021

BUY
$274.82 - $308.34 $814,841 - $914,228
2,965 Added 7.55%
42,211 $11.9 Million
Q2 2021

Jul 16, 2021

BUY
$251.87 - $278.14 $1.15 Million - $1.26 Million
4,547 Added 13.1%
39,246 $10.8 Million
Q1 2021

May 05, 2021

BUY
$204.88 - $255.03 $122,928 - $153,018
600 Added 1.76%
34,699 $8.85 Million
Q4 2020

Feb 03, 2021

BUY
$186.91 - $214.42 $312,887 - $358,939
1,674 Added 5.16%
34,099 $6.94 Million
Q3 2020

Oct 28, 2020

SELL
$167.03 - $201.3 $351,598 - $423,736
-2,105 Reduced 6.1%
32,425 $6.11 Million
Q2 2020

Aug 20, 2020

BUY
$113.31 - $182.44 $3.91 Million - $6.3 Million
34,530 New
34,530 $5.74 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.3B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Shikiar Asset Management Inc Portfolio

Follow Shikiar Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Shikiar Asset Management Inc with notifications on news.